US pharma AbbVie has put compatriot Allergan’s women’s health business up for sale. The company is said to be working with Morgan Stanley on an auction process that has...
04.10.2019
- The US Federal Trade Commission (FTC) has requested additional information from both Allergan and AbbVie as it digs deeper into the proposed merger of the two drugmakers. Biopharma...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
03.09.2019
- After Johnson & Johnson last week was ordered to pay $572 million to the state of Oklahoma, analysts and other observers said the verdict could prompt other opioid makers to think...
27.06.2019
- In a deal expected to close early next year, US biopharma AbbVie is buying troubled Botox manufacturer Allergan for $63 billion in cash and shares. The acquisition is the second...
20.09.2018
- Drugmaker Allergan is buying Bonti, a privately held, clinical-stage biotech based in Newport Beach, California, USA, that develops novel, fast-acting neurotoxin programs for...
05.01.2018
- Pershing Square, the hedge fund of US activist investor Bill Ackman, and Canada-based drugmaker Valeant Pharmaceuticals have agreed in principle to pay $290 million to settle two...
15.12.2017
- As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...
